Definium Therapeutics Inc.

DFTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$33.85

-$2.48 (-6.83%)

Nov 2, 2026, 12:02 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Net Income	-183.79M	-108.68M	-95.73M	-56.8M	-93.04M	-33.94M
Depreciation & Amortization	n/a	527K	3.16M	3.18M	2.62M	n/a
Stock-Based Compensation	20.1M	16.91M	15.49M	13.71M	42.72M	7.41M
Other Working Capital	6.1M	-1.22M	4.26M	-1.73M	598K	1.52M
Other Non-Cash Items	22.7M	15.45M	8.46M	-6.45M	1.16M	873K
Deferred Income Tax	n/a	n/a	-2.03M	n/a	-1.16M	n/a
Change in Working Capital	9.44M	-3.34M	6.28M	-3.78M	1.88M	2.06M
Operating Cash Flow	-131.56M	-79.13M	-64.37M	-50.14M	-45.82M	-23.6M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	-297K	n/a
Purchase of Investments	-268.36M	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	116.75M	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-151.61M	n/a	n/a	n/a	-297K	n/a
Debt Repayment	20M	10.86M	14.16M	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-12.63M	-7.66M	163K	16.75M	16.9M	24.71M
Financial Cash Flow	267.27M	253.2M	21.85M	59.05M	98.82M	96.7M
Net Cash Flow	-15.9M	174.04M	-42.44M	8.6M	53.45M	73.39M
Free Cash Flow	-131.56M	-79.13M	-64.37M	-50.14M	-45.82M	-23.6M
Adj. Free Cash Flow	-151.66M	-96.04M	-79.86M	-63.85M	-88.54M	-31M
Maintenance CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-131.56M	-79.13M	-64.37M	-50.14M	-45.82M	-23.6M